Flash Solution News Today

NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment...

NovaBay® Pharmaceuticals, Inc. , a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message...

NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3.

Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova® physician dispensed and OTC channels, and from branded wound care...

NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an...

NovaBay Pharmaceuticals, Inc. announces a 64% increase in online subscription-based unit sales for its Avenova® Lid & Lash Spray Solution and a 38% increase in subscription-based customers in 2023...

NovaBay Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. today announced an agreement for the sale and marketing of Avenova®-branded products by Sonoma in the European Union. The new...

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market ...

NovaBay Pharmaceuticals, Inc. announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held Thursday,...

NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023 and will hold...